Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3350775
Max Phase: Preclinical
Molecular Formula: C27H29NNaO13P
Molecular Weight: 607.51
Molecule Type: Small molecule
Associated Items:
ID: ALA3350775
Max Phase: Preclinical
Molecular Formula: C27H29NNaO13P
Molecular Weight: 607.51
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(C)=O)C[C@@H]3O[C@H]1C[C@@H](N)[C@H](OP(=O)([O-])O)[C@H](C)O1.[Na+]
Standard InChI: InChI=1S/C27H30NO13P.Na/c1-10-26(41-42(35,36)37)14(28)7-17(39-10)40-16-9-27(34,11(2)29)8-13-19(16)25(33)21-20(23(13)31)22(30)12-5-4-6-15(38-3)18(12)24(21)32;/h4-6,10,14,16-17,26,31,33-34H,7-9,28H2,1-3H3,(H2,35,36,37);/q;+1/p-1/t10-,14+,16-,17-,26+,27-;/m0./s1
Standard InChI Key: PDOSXWCYPZTROB-XDKGUSKUSA-M
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 607.51 | Molecular Weight (Monoisotopic): 607.1455 | AlogP: 1.15 | #Rotatable Bonds: 6 |
Polar Surface Area: 232.37 | Molecular Species: ZWITTERION | HBA: 12 | HBD: 6 |
#RO5 Violations: 3 | HBA (Lipinski): 14 | HBD (Lipinski): 7 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 0.83 | CX Basic pKa: 10.07 | CX LogP: 1.18 | CX LogD: -0.18 |
Aromatic Rings: 2 | Heavy Atoms: 42 | QED Weighted: 0.17 | Np Likeness Score: 1.71 |
1. Leenders RG, Scheeren HW, Houba PH, Boven E, Haisma HJ. (1995) Synthesis and evaluation of novel daunomycin-phosphate-sulfate --glucuronide and --glucoside prodrugs for application in adept, 5 (24): [10.1016/0960-894X(95)00523-3] |
Source(1):